Pasithea Therapeutics (Pasithea Therapeutics) Additional Paid-In Capital : $59.07 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pasithea Therapeutics Additional Paid-In Capital?

Pasithea Therapeutics's quarterly additional paid-in capital increased from Sep. 2023 ($58.63 Mil) to Dec. 2023 ($58.72 Mil) and increased from Dec. 2023 ($58.72 Mil) to Mar. 2024 ($59.07 Mil).

Pasithea Therapeutics's annual additional paid-in capital increased from Dec. 2021 ($53.63 Mil) to Dec. 2022 ($61.86 Mil) but then declined from Dec. 2022 ($61.86 Mil) to Dec. 2023 ($58.72 Mil).

Pasithea Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for Pasithea Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pasithea Therapeutics Additional Paid-In Capital Chart

Pasithea Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

0.27

53.63

61.86

58.72

Pasithea Therapeutics Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial										62.02	62.23	58.63	58.72	59.07

Pasithea Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Pasithea Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pasithea Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Pasithea Therapeutics (Pasithea Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pasithea Therapeutics Corp (NAS:KTTAW) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

KTTA:USA

Address

1111 Lincoln Road, Suite 500, Miami Beach, FL, USA, 33139

Website

https://www.pasithea.com

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.